A. Heddini, Malaria pathogenesis: a jigsaw with an increasing number of pieces, Int J Parasitol, vol.32, p.187, 2002.

Q. Cheng, D. E. Kyle, and M. L. Gatton, Artemisinin resistance in Plasmodium falciparum: a process linked to dormancy?, Int J Parasitol Drugs Drug Resist, vol.2, pp.249-255, 2012.

C. Deregnaucourt and J. Schrevel, Bee venom phospholipase A2 induces stage-specific growth arrest of the intraerythrocytic Plasmodium falciparum via modifications of human serum components, J Biol Chem, vol.275, pp.39973-39980, 2000.

C. Guillaume, C. Deregnaucourt, V. Clavey, and J. Schrevel, Anti-Plasmodium properties of group IA, IB, IIA and III secreted phospholipases A2 are serum-dependent, Toxicon, vol.43, pp.311-318, 2004.

G. N. Moll, H. J. Vial, F. C. Van-der-wiele, M. L. Ancelin, B. Roelofsen et al., Selective elimination of malaria infected erythrocytes by a modified phospholipase A2 in vitro, Biochim Biophys Acta, vol.1024, pp.189-192, 1990.

C. Guillaume, C. Calzada, M. Lagarde, J. Schrevel, and C. Deregnaucourt, Interplay between lipoproteins and bee venom phospholipase A2 in relation to their anti-Plasmodium toxicity, J Lipid Res, vol.47, pp.1493-1506, 2006.

E. Valentin and G. Lambeau, Increasing molecular diversity of secreted phospholipases A2 and their receptors and binding proteins, Biochim Biophys Acta, vol.1488, pp.59-70, 2000.

E. A. Dennis, J. Cao, Y. H. Hsu, V. Magrioti, and G. Kokotos, Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention, Chem Rev, vol.111, pp.6130-6185, 2011.

G. Lambeau and M. H. Gelb, Biochemistry and physiology of mammalian secreted phospholipases A2, Annu Rev Biochem, vol.77, pp.495-520, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00315356

M. Murakami, Y. Taketomi, C. Girard, K. Yamamoto, and G. Lambeau, Emerging roles of secreted phospholipase A2 enzymes: lessons from transgenic and knockout mice, Biochimie, vol.92, pp.561-582, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00497527

A. G. Singer, F. Ghomashchi, L. Calvez, C. Bollinger, J. Bezzine et al., Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J Biol Chem, vol.277, pp.48535-48549, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00090925

L. M. Madsen, M. Inada, and J. Weiss, Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli, Infect Immun, vol.64, pp.2425-2430, 1996.

X. D. Qu and R. I. Lehrer, Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears, Infect Immun, vol.66, pp.2791-2797, 1998.

V. J. Laine, D. S. Grass, and T. J. Nevalainen, Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection, Infect Immun, vol.68, pp.87-92, 2000.

B. P. Hurley and B. A. Mccormick, Multiple roles of phospholipase A2 during lung infection and inflammation, Infect Immun, vol.76, pp.2259-2272, 2008.

T. J. Nevalainen, G. G. Graham, and K. F. Scott, Antibacterial actions of secreted phospholipases A2, Rev Biochim Biophys Acta, vol.1781, pp.1-9, 2008.

N. Degousee, D. J. Kelvin, G. Geisslinger, D. M. Hwang, E. Stefanski et al., Group V phospholipase A2 in bone marrow-derived myeloid cells and bronchial epithelial cells promotes bacterial clearance after Escherichia coli pneumonia, J Biol Chem, vol.286, pp.35650-35662, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00731361

E. Movert, Y. Wu, G. Lambeau, F. Kahn, L. Touqui et al., Secreted group IIA phospholipase A2 protects humans against the group B Streptococcus: experimental and clinical evidence, J Infect Dis, vol.208, pp.2025-2035, 2013.

A. A. Kelvin, N. Degousee, D. Banner, E. Stefanski, A. J. Leomicronn et al., Lack of group X secreted phospholipase A2 increases survival following pandemic H1N1 influenza infection, Virology, vol.454, pp.78-92, 2014.

E. Pernet, L. Guillemot, P. Burgel, C. Martin, G. Lambeau et al., Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity, Nat Commun, vol.5, p.5105, 2014.

B. Balestrieri, A. Maekawa, W. Xing, M. H. Gelb, H. R. Katz et al., Group V secretory phospholipase A2 modulates phagosome maturation and regulates the innate immune response against Candida albicans, J Immunol, vol.182, pp.4891-4898, 2009.

P. Vadas, J. Keystone, E. Stefanski, K. Scott, and W. Pruzanski, Induction of circulating group II phospholipase A2 expression in adults with malaria, Infect Immun, vol.60, pp.3928-3931, 1992.

P. Vadas, T. E. Taylor, L. Chimsuku, D. Goldring, E. Stefanski et al., Increased serum phospholipase A2 activity in Malawian children with falciparum malaria, Am J Trop Med Hyg, vol.49, pp.455-459, 1993.

B. A. Sin, M. Akdis, J. Zumkehr, S. Bezzine, C. Bekpen et al., T-cell and antibody responses to phospholipase A(2) from different species show distinct cross-reactivity patterns, Allergy, vol.66, pp.1513-1521, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00731426

I. Jemel, H. Ii, R. C. Oslund, C. Payre, A. S. Dabert-gay et al., Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells, J Biol Chem, vol.286, pp.36509-36521, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00731333

B. P. Smart, R. C. Oslund, L. A. Walsh, and M. H. Gelb, The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding, J Med Chem, vol.49, pp.2858-2860, 2006.

W. Trager and J. B. Jensen, Human malaria parasites in continuous culture, Science, vol.193, pp.673-675, 1976.

C. Lambros and J. P. Vanderberg, Synchronization of Plasmodium falciparum erythrocytic stages in culture, J Parasitol, vol.65, pp.418-420, 1979.

R. E. Desjardins, C. J. Canfield, J. D. Haynes, and J. D. Chulay, Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique, Antimicrob Agents Chemother, vol.16, pp.710-718, 1979.

R. J. Havel, H. A. Eder, and J. H. Bragdon, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J Clin Invest, vol.34, pp.1345-1353, 1955.

J. G. Bollinger, H. Ii, M. Sadilek, and M. H. Gelb, Improved method for the quantification of lysophospholipids including enol ether species by liquid chromatography-tandem mass spectrometry, J Lipid Res, vol.51, pp.440-447, 2010.

J. G. Bollinger, G. S. Naika, M. Sadilek, and M. H. Gelb, LC/ESI-MS/MS detection of FAs by charge reversal derivatization with more than four orders of magnitude improvement in sensitivity, J Lipid Res, vol.54, pp.3523-3530, 2013.

V. P. Dole, A relation between non-esterified fatty acids in plasma and the metabolism of glucose, J Clin Invest, vol.35, pp.150-154, 1956.

J. T. Dodge, C. Mitchell, and D. J. Hanahan, The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes, Arch Biochem Biophys, vol.100, issue.63, pp.90042-90042, 1963.

F. Surrel, I. Jemel, E. Boilard, J. G. Bollinger, C. Payré et al., Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators, Mol Pharmacol, vol.76, pp.778-790, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417688

B. P. Smart, Y. H. Pan, A. K. Weeks, J. G. Bollinger, B. J. Bahnson et al., Inhibition of the complete set of mammalian secreted phospholipases A2 by indole analogues: a structure-guided study, Bioorg Med Chem Lett, vol.12, pp.1737-1749, 2004.

E. D. Olson, J. Nelson, K. Griffith, T. Nguyen, M. Streeter et al., Kinetic evaluation of cell membrane hydrolysis during apoptosis by human isoforms of secretory phospholipase A2, J Biol Chem, vol.285, pp.10993-11002, 2010.

N. A. Neidlinger, S. K. Larkin, A. Bhagat, G. P. Victorino, and F. A. Kuypers, Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction, J Biol Chem, vol.281, pp.775-781, 2006.

P. A. Maguire, J. Prudhomme, and I. W. Sherman, Alterations in erythrocyte membrane phospholipid organization due to the intracellular growth of the human malaria parasite, Plasmodium falciparum. Parasitology, vol.2, pp.179-186, 1991.

D. K. Singh and P. V. Subbaiah, Modulation of the activity and arachidonic acid selectivity of group X secretory phospholipase A2 by sphingolipids, J Lipid Res, vol.48, pp.683-692, 2007.

W. Pruzanski, G. Lambeau, M. Lazdunski, W. Cho, J. Kopilov et al., Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2, Biochim Biophys Acta, vol.1736, pp.38-50, 2005.

K. Hanasaki, K. Yamada, S. Yamamoto, Y. Ishimoto, A. Saiga et al., Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation, J Biol Chem, vol.277, pp.29116-29124, 2002.

B. Rosengren, A. C. Jonsson-rylander, H. Peilot, G. Camejo, and E. Hurt-camejo, Distinctiveness of secretory phospholipase A2 group IIA and V suggesting unique roles in atherosclerosis, Biochim Biophys Acta, vol.1761, pp.1301-1308, 2006.

H. Sato, R. Kato, Y. Isogai, G. Saka, M. Ohtsuki et al., Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis, J Biol Chem, vol.283, pp.33483-33497, 2008.

L. M. Kumaratilake, B. S. Robinson, A. Ferrante, and A. Poulos, Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in vitro effects on Plasmodium falciparum and in vivo effects on P. berghei, J Clin Invest, vol.89, pp.961-967, 1992.

Y. Ishimoto, K. Yamada, S. Yamamoto, T. Ono, M. Notoya et al., Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions, Biochim Biophys Acta, vol.1642, issue.03, pp.120-124, 2003.

A. Kuksis and W. Pruzanski, Phase composition of lipoprotein SM/ cholesterol/PtdCho affects FA specificity of sPLA2s, J Lipid Res, vol.49, pp.2161-2168, 2008.

W. Pruzanski, G. Lambeau, M. Lazdunski, W. Cho, J. Kopilov et al., Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2, Biochim Biophys Acta, vol.1771, pp.5-19, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00170653

K. Yamamoto, Y. Isogai, H. Sato, Y. Taketomi, and M. Murakami, Secreted phospholipase A2, lipoprotein hydrolysis, and atherosclerosis: integration with lipidomics, Anal Bioanal Chem, vol.400, pp.1829-1842, 2011.

L. Gesquiere, W. Cho, and P. V. Subbaiah, Role of group IIa and group V secretory phospholipases A2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin, Biochemistry, vol.41, pp.4911-4920, 2002.

Y. Weinrauch, C. Abad, N. S. Liang, S. F. Lowry, and J. Weiss, Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2, J Clin Invest, vol.102, pp.633-638, 1998.

D. Fenard, G. Lambeau, E. Valentin, J. C. Lefebvre, M. Lazdunski et al., Secreted phospholipases A2, a new class of HIV inhibitors that block virus entry into host cells, J Clin Invest, vol.104, pp.611-618, 1999.

J. O. Kim, B. K. Chakrabarti, A. Guha-niyogi, M. K. Louder, J. R. Mascola et al., Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2, J Virol, vol.81, pp.1444-1450, 2007.

M. Mitsuishi, S. Masuda, I. Kudo, and M. Murakami, Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species, Biochim Biophys Acta, vol.1771, pp.1389-1396, 2007.

D. K. Singh, L. R. Gesquiere, and P. V. Subbaiah, Role of sphingomyelin and ceramide in the regulation of the activity and fatty acid specificity of group V secretory phospholipase A2, Arch Biochem Biophys, vol.459, pp.280-287, 2007.

W. Pruzanski, E. Stefanski, F. C. De-beer, M. C. De-beer, P. Vadas et al., Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDL, J Lipid Res, vol.39, pp.2150-2160, 1998.

R. Eckey, M. Menschikowski, P. Lattke, and W. Jaross, Minimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2, Atherosclerosis, vol.132, pp.88-97, 1997.

N. Sibmooh, P. Yamanont, S. Krudsood, W. Leowattana, G. Brittenham et al., Increased fluidity and oxidation of malarial lipoproteins: relation with severity and induction of endothelial expression of adhesion molecules, Lipids Health Dis, vol.3, p.15, 2004.

E. Pongponratn, G. D. Turner, N. P. Day, N. H. Phu, J. A. Simpson et al., An ultrastructural study of the brain in fatal Plasmodium falciparum malaria, Am J Trop Med Hyg, vol.69, pp.345-359, 2003.

V. Combes, N. Coltel, D. Faille, S. C. Wassmer, and G. E. Grau, Cerebral malaria: role of microparticles and platelets in alterations of the bloodbrain barrier, Int J Parasitol, vol.36, pp.541-546, 2006.

N. Degousee, F. Ghomashchi, E. Stefanski, A. Singer, B. P. Smart et al., Groups IV, V and X phospholipases A2 in human neutrophils. Role in eicosanoid production and gram negative bacterial phospholipid hydrolysis, J Biol Chem, vol.277, pp.5061-5073, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00090943

G. Giannattasio, Y. Lai, F. Granata, C. M. Mounier, L. Nallan et al., Expression of phospholipases A2 in primary human lung macrophages Role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis, Biochim Biophys Acta, vol.1791, pp.92-102, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417727

P. N. Bernatchez, M. V. Winstead, E. A. Dennis, and M. G. Sirois, VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2, Br J Pharmacol, vol.134, pp.197-205, 2001.

D. Mazier, J. Nitcheu, and M. Idrissa-boubou, Cerebral malaria and immunogenetics, Parasite Immunol, vol.22, pp.613-623, 2000.

S. A. Karabina, I. Brocheriou, L. Naour, G. Agrapart, M. Durand et al., Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function, FASEB J, vol.20, pp.2547-2549, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00170587

M. Triggiani, G. Giannattasio, C. Calabrese, S. Loffredo, F. Granata et al., Lung mast cells are a source of secreted phospholipases A2, J Allergy Clin Immunol, vol.124, pp.558-565, 2009.

M. Triggiani, F. Granata, G. Giannattasio, and G. Marone, Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes, J Allergy Clin Immunol, vol.116, pp.1000-1006, 2005.

M. Murakami, K. Yoshihara, S. Shimbara, G. Lambeau, M. H. Gelb et al., Cellular arachidonate-releasing function and inflammation-associated expression of group IIF secretory phospholipase A2, J Biol Chem, vol.277, pp.19145-19155, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00090930

D. Cruz, A. D. Watson, C. S. Miller, D. Montoya, M. T. Ochoa et al., Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy, J Clin Invest, vol.118, pp.2917-2928, 2008.

Z. Mallat, G. Lambeau, and A. Tedgui, Lipoprotein-associated and secreted phospholipases A2 in cardiovascular disease: roles as biological effectors and biomarkers, Circulation, vol.122, pp.2183-2200, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00731434

X. Jiang, Z. Yang, A. N. Chandrakala, D. Pressley, and S. Parthasarathy, Oxidized low density lipoproteins-do we know enough about them? Cardiovasc, Drugs Ther, vol.25, pp.367-377, 2011.